Multi-Modal Medical Image Fusion (MMMIF) has become increasingly important in clinical applications, as it enables the integration of complementary information from different imaging modalities to support more accurate diagnosis and treatment planning. The primary objective of Medical Image Fusion (MIF) is to generate a fused image that retains the most informative features from the Source Images (SI), thereby enhancing the reliability of clinical decision-making systems. However, due to inherent limitations in individual imaging modalities-such as poor spatial resolution in functional images or low contrast in anatomical scans-fused images can suffer from information degradation or distortion. To address these limitations, this study proposes a novel fusion framework that integrates the Non-Subsampled Shearlet Transform (NSST) with a Convolutional Neural Network (CNN) for effective sub-band enhancement and image reconstruction. Initially, each source image is decomposed into Low-Frequency Coefficients (LFC) and multiple High-Frequency Coefficients (HFC) using NSST. The proposed Concurrent Denoising and Enhancement Network (CDEN) is then applied to these sub-bands to suppress noise and enhance critical structural details. The enhanced LFCs are fused using an AlexNet-based activity-level fusion model, while the enhanced HFCs are combined using a Pulse Coupled Neural Network (PCNN) guided by a Novel Sum-Modified Laplacian (NSML) metric. Finally, the fused image is reconstructed via Inverse-NSST (I-NSST). Experimental results prove that the proposed method outperforms existing fusion algorithms, achieving approximately 16.5% higher performance in terms of the QAB/F (edge preservation) metric, along with strong results across both subjective visual assessments and objective quality indices.

Multimodal medical image fusion (MMIF) aims to integrate images from different modalities to produce a comprehensive image that enhances medical diagnosis by accurately depicting organ structures, tissue textures, and metabolic information. Capturing both the unique and complementary information across multiple modalities simultaneously is a key research challenge in MMIF. To address this challenge, this paper proposes a novel image fusion method, MMIF-AMIN, which features a new architecture that can effectively extract these unique and complementary features. Specifically, an Invertible Dense Network (IDN) is employed for lossless feature extraction from individual modalities. To extract complementary information between modalities, a Multi-scale Complementary Feature Extraction Module (MCFEM) is designed, which incorporates a hybrid attention mechanism, convolutional layers of varying sizes, and Transformers. An adaptive loss function is introduced to guide model learning, addressing the limitations of traditional manually-designed loss functions and enhancing the depth of data mining. Extensive experiments demonstrate that MMIF-AMIN outperforms nine state-of-the-art MMIF methods, delivering superior results in both quantitative and qualitative analyses. Ablation experiments confirm the effectiveness of each component of the proposed method. Additionally, extending MMIF-AMIN to other image fusion tasks also achieves promising performance.

Achieving clinical level performance and widespread deployment for generating radiology impressions encounters a giant challenge for conventional artificial intelligence models tailored to specific diseases and organs. Concurrent with the increasing accessibility of radiology reports and advancements in modern general AI techniques, the emergence and potential of deployable radiology AI exploration have been bolstered. Here, we present ChatRadio-Valuer, the first general radiology diagnosis large language model for localized deployment within hospitals and being close to clinical use for multi-institution and multi-system diseases. ChatRadio-Valuer achieved 15 state-of-the-art results across five human systems and six institutions in clinical-level events (n=332,673) through rigorous and full-spectrum assessment, including engineering metrics, clinical validation, and efficiency evaluation. Notably, it exceeded OpenAI's GPT-3.5 and GPT-4 models, achieving superior performance in comprehensive disease diagnosis compared to the average level of radiology experts. Besides, ChatRadio-Valuer supports zero-shot transfer learning, greatly boosting its effectiveness as a radiology assistant, while ensuring adherence to privacy standards and being readily utilized for large-scale patient populations. Our expeditions suggest the development of localized LLMs would become an imperative avenue in hospital applications.

Accurately grounding regions of interest (ROIs) is critical for diagnosis and treatment planning in medical imaging. While multimodal large language models (MLLMs) combine visual perception with natural language, current medical-grounding pipelines still rely on supervised fine-tuning with explicit spatial hints, making them ill-equipped to handle the implicit queries common in clinical practice. This work makes three core contributions. We first define Unified Medical Reasoning Grounding (UMRG), a novel vision-language task that demands clinical reasoning and pixel-level grounding. Second, we release U-MRG-14K, a dataset of 14K samples featuring pixel-level masks alongside implicit clinical queries and reasoning traces, spanning 10 modalities, 15 super-categories, and 108 specific categories. Finally, we introduce MedReasoner, a modular framework that distinctly separates reasoning from segmentation: an MLLM reasoner is optimized with reinforcement learning, while a frozen segmentation expert converts spatial prompts into masks, with alignment achieved through format and accuracy rewards. MedReasoner achieves state-of-the-art performance on U-MRG-14K and demonstrates strong generalization to unseen clinical queries, underscoring the significant promise of reinforcement learning for interpretable medical grounding.

Generative AI holds great potentials to automate and enhance data synthesis in nuclear medicine. However, the high-stakes nature of biomedical imaging necessitates robust mechanisms to detect and manage unexpected or erroneous model behavior. We introduce development and implementation of a hybrid anomaly detection framework to safeguard GenAI models in BIOEMTECH's eyes(TM) systems. Two applications are demonstrated: Pose2Xray, which generates synthetic X-rays from photographic mouse images, and DosimetrEYE, which estimates 3D radiation dose maps from 2D SPECT/CT scans. In both cases, our outlier detection (OD) enhances reliability, reduces manual oversight, and supports real-time quality control. This approach strengthens the industrial viability of GenAI in preclinical settings by increasing robustness, scalability, and regulatory compliance.

The core role of medical images in disease diagnosis makes their quality directly affect the accuracy of clinical judgment. However, due to factors such as low-dose scanning, equipment limitations and imaging artifacts, medical images are often accompanied by non-uniform noise interference, which seriously affects structure recognition and lesion detection. This paper proposes a medical image adaptive denoising model (MI-ND) that integrates multi-scale convolutional and Transformer architecture, introduces a noise level estimator (NLE) and a noise adaptive attention module (NAAB), and realizes channel-spatial attention regulation and cross-modal feature fusion driven by noise perception. Systematic testing is carried out on multimodal public datasets. Experiments show that this method significantly outperforms the comparative methods in image quality indicators such as PSNR, SSIM, and LPIPS, and improves the F1 score and ROC-AUC in downstream diagnostic tasks, showing strong prac-tical value and promotional potential. The model has outstanding benefits in structural recovery, diagnostic sensitivity, and cross-modal robustness, and provides an effective solution for medical image enhancement and AI-assisted diagnosis and treatment.

This clinically oriented review explores the technical advancements of simultaneous PET/magnetic resonance (MR) imaging to provide an overview of the addressed obstacles over time, current challenges, and future trends in the field. In particular, advanced attenuation and motion correction techniques and MR-guided PET reconstruction frameworks were reviewed, and the state-of-the-art PET/MR systems and their strengths were discussed. Overall, PET/MR holds great potential in various clinical applications, including oncology, neurology, and cardiology. However, it requires continued optimization in hardware, algorithms, and clinical protocols to achieve broader adoption and be included in the routine clinical standards.

Generative artificial intelligence models facilitate open-data sharing by proposing synthetic data as surrogates of real patient data. Despite the promise for healthcare, some of these models are susceptible to patient data memorization, where models generate patient data copies instead of novel synthetic samples, resulting in patient re-identification. Here we assess memorization in unconditional latent diffusion models by training them on a variety of datasets for synthetic data generation and detecting memorization with a self-supervised copy detection approach. We show a high degree of patient data memorization across all datasets, with approximately 37.2% of patient data detected as memorized and 68.7% of synthetic samples identified as patient data copies. Latent diffusion models are more susceptible to memorization than autoencoders and generative adversarial networks, and they outperform non-diffusion models in synthesis quality. Augmentation strategies during training, small architecture size and increasing datasets can reduce memorization, while overtraining the models can enhance it. These results emphasize the importance of carefully training generative models on private medical imaging datasets and examining the synthetic data to ensure patient privacy.

Medicine is one of the most sensitive fields in which artificial intelligence (AI) is extensively used, spanning from medical image analysis to clinical support. Specifically, in medicine, where every decision may severely affect human lives, the issue of ensuring that AI systems operate ethically and produce results that align with ethical considerations is of great importance. In this work, we investigate the combination of several key parameters on the performance of artificial neural networks (ANNs) used for medical image analysis in the presence of data corruption or errors. For this purpose, we examined five different ANN architectures (AlexNet, LeNet 5, VGG16, ResNet-50, and Vision Transformers - ViT), and for each architecture, we checked its performance under varying combinations of training dataset sizes and percentages of images that are corrupted through mislabeling. The image mislabeling simulates deliberate or nondeliberate changes to the dataset, which may cause the AI system to produce unreliable results. We found that the five ANN architectures produce different results for the same task, both for cases with and without dataset modification, which implies that the selection of which ANN architecture to implement may have ethical aspects that need to be considered. We also found that label corruption resulted in a mixture of performance metrics tendencies, indicating that it is difficult to conclude whether label corruption has occurred. Our findings demonstrate the relation between ethics in AI and ANN architecture implementation and AI computational parameters used therefor, and raise awareness of the need to find appropriate ways to determine whether label corruption has occurred.

Enhancing the accuracy of tumor response predictions enables the development of tailored therapeutic strategies for patients with breast cancer. In this study, we developed deep radiomic models to enhance the prediction of chemotherapy response after the first treatment cycle. 18F-Fludeoxyglucose PET/CT imaging data and clinical record from 60 breast cancer patients were retrospectively obtained from the Cancer Imaging Archive. PET/CT scans were conducted at three distinct stages of treatment; prior to the initiation of chemotherapy (T1), following the first cycle of chemotherapy (T2), and after the full chemotherapy regimen (T3). The patient's primary gross tumor volume (GTV) was delineated on PET images using a 40% threshold of the maximum standardized uptake value (SUVmax). Radiomic features were extracted from the GTV based on the PET/CT images. In addition, a squeeze-and-excitation network (SENet) deep learning model was employed to generate additional features from the PET/CT images for combined analysis. A XGBoost machine learning model was developed and compared with the conventional machine learning algorithm [random forest (RF), logistic regression (LR) and support vector machine (SVM)]. The performance of each model was assessed using receiver operating characteristics area under the curve (ROC AUC) analysis, and prediction accuracy in a validation cohort. Model performance was evaluated through fivefold cross-validation on the entire cohort, with data splits stratified by treatment response categories to ensure balanced representation. The AUC values for the machine learning models using only radiomic features were 0.85(XGBoost), 0.76 (RF), 0.80 (LR), and 0.59 (SVM), with XGBoost showing the best performance. After incorporating additional deep learning-derived features from SENet, the AUC values increased to 0.92, 0.88, 0.90, and 0.61, respectively, demonstrating significant improvements in predictive accuracy. Predictions were based on pre-treatment (T1) and post-first-cycle (T2) imaging data, enabling early assessment of chemotherapy response after the initial treatment cycle. Integrating deep learning-derived features significantly enhanced the performance of predictive models for chemotherapy response in breast cancer patients. This study demonstrated the superior predictive capability of the XGBoost model, emphasizing its potential to optimize personalized therapeutic strategies by accurately identifying patients unlikely to respond to chemotherapy after the first treatment cycle.